Drug combination extends survival in refractory lung cancer patients, study finds
Thursday, June 2, 2011 - 09:30
in Health & Medicine
A combination of two FDA-approved drugs extend survival in advanced-stage lung cancer patients who have run out of treatment options, according to a new study.